StonvexLoading…
StonvexStonvexStonvexCore line items from CGON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.08M | $4.04M | $1.72M | $52.00K |
Operating Income | $-66.39M | $-190.77M | $-142.07M | $-90.94M |
Net Income | $-60.20M | $-161.00M | $-119.69M | $-41.43M |
EPS (Diluted) | $-0.71 | $-2.08 | $-1.57 | $-1.00 |
Total Assets | $1.14B | $791.59M | $729.91M | $701.45M |
Total Liabilities | $43.48M | $38.99M | $42.27M | $31.09M |
Cash & Equivalents | $33.70M | $32.49M | $45.15M | $14.62M |
Free Cash Flow OCF − CapEx | $-57.25M | $-132.48M | $-96.26M | $-57.27M |
Shares Outstanding | 88.01M | 80.69M | 78.28M | 76.23M |